These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 18464498)
1. [Regenerative medicine: history and perspectives]. Okabayashi K; Asashima M Nihon Rinsho; 2008 May; 66(5):825-30. PubMed ID: 18464498 [TBL] [Abstract][Full Text] [Related]
2. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells. Romano G Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350 [TBL] [Abstract][Full Text] [Related]
3. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells. Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228 [TBL] [Abstract][Full Text] [Related]
4. Prospects of induced pluripotent stem cell technology in regenerative medicine. Zhang F; Citra F; Wang DA Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760 [TBL] [Abstract][Full Text] [Related]
5. [Review of basic studies about the cardiac stem cell and regenerative medicine]. Tamura Y; Fukuda K Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509 [TBL] [Abstract][Full Text] [Related]
6. [Ethical, legal and social issues in regenerative medicine]. Ida R Nihon Rinsho; 2008 May; 66(5):991-6. PubMed ID: 18464522 [TBL] [Abstract][Full Text] [Related]
8. ES and iPS cell research for cardiovascular regeneration. Yamashita JK Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126 [TBL] [Abstract][Full Text] [Related]
9. [Establishment of human embryonic stem cell lines and their therapeutic application]. Suemori H Rinsho Byori; 2004 Mar; 52(3):254-8. PubMed ID: 15137326 [TBL] [Abstract][Full Text] [Related]
10. Recent progressions in stem cell research: breakthroughs achieved and challenges faced. Tani J; Umbas R Acta Med Indones; 2009 Jan; 41(1):30-5. PubMed ID: 19258678 [TBL] [Abstract][Full Text] [Related]
11. Transplantation tolerance in an age of induced pluripotency. Fairchild PJ Curr Opin Organ Transplant; 2009 Aug; 14(4):321-5. PubMed ID: 19542888 [TBL] [Abstract][Full Text] [Related]
12. The significance of induced pluripotent stem cells for basic research and clinical therapy. Meyer JR J Med Ethics; 2008 Dec; 34(12):849-51. PubMed ID: 19043107 [TBL] [Abstract][Full Text] [Related]
13. iPS cell technology in regenerative medicine. Lengner CJ Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216 [TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Amabile G; Meissner A Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546 [TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells. Lee H; Park J; Forget BG; Gaines P Regen Med; 2009 Sep; 4(5):759-69. PubMed ID: 19761400 [TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of human induced pluripotent stem cells. Ohnuki M; Takahashi K; Yamanaka S Curr Protoc Stem Cell Biol; 2009 Jun; Chapter 4():Unit 4A.2. PubMed ID: 19536759 [TBL] [Abstract][Full Text] [Related]
17. Human stem cell research and regenerative medicine--present and future. Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982 [TBL] [Abstract][Full Text] [Related]
18. Improvement of mouse cloning using nuclear transfer-derived embryonic stem cells and/or histone deacetylase inhibitor. Wakayama S; Wakayama T Int J Dev Biol; 2010; 54(11-12):1641-8. PubMed ID: 21404185 [TBL] [Abstract][Full Text] [Related]